Modeling Chronic Glycemic Exposure Variables as Correlates and Predictors of Microvascular Complications of Diabetes
Open Access
- 1 October 2006
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 29 (10), 2282-2288
- https://doi.org/10.2337/dc06-0525
Abstract
OBJECTIVE—The degree to which chronic glycemic exposure (CGE) (fasting plasma glucose [FPG], HbA1c [A1C], duration of diabetes, age at onset of diabetes, or combinations of these) is associated with or predicts the severity of microvessel complications is unsettled. Specifically, we test whether combinations of components correlate and predict complications better than individual components. RESEARCH DESIGN AND METHODS—Correlations and predictions of CGE and complications were assessed in the Rochester Diabetic Neuropathy Study, a population-based, cross-sectional, and longitudinal epidemiologic survey of 504 patients with diabetes followed for up to 20 years. RESULTS—In multivariate analysis, A1C and duration of diabetes (and to a lesser degree age at onset of diabetes but not FPG) were the main significant CGE risk covariates for complications. A derived glycemic exposure index (GEi) correlated with and predicted complications better than did individual components. Composite or staged measures of polyneuropathy provided higher correlations and better predictions than did dichotomous measures of whether polyneuropathy was present or not. Generally, the mean GEi was significantly higher with increasing stages of severity of complications. CONCLUSIONS—A combination of A1C, duration of diabetes, and age at onset of diabetes (a mathematical index, GEi) correlates significantly with complications and predicts later complications better than single components of CGE. Serial measures of A1C improved the correlations and predictions. For polyneuropathy, continuous or staged measurements performed better than dichotomous judgments. Even with intensive assessment of CGE and complications over long times, only about one-third of the variability of the severity of complications is explained, emphasizing the role of other putative risk covariates.Keywords
This publication has 29 references indexed in Scilit:
- Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetesNature Genetics, 2006
- Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunctionNature Genetics, 2005
- Monotonicity of Nerve Tests in DiabetesDiabetes Care, 2005
- History of standard scoring, notation, and summation of neuromuscular signs. A current survey and recommendationJournal of the Peripheral Nervous System, 2005
- Individual attributes versus composite scores of nerve conduction abnormality: Sensitivity, reproducibility, and concordance with impairmentMuscle & Nerve, 2003
- Biochemistry and molecular cell biology of diabetic complicationsNature, 2001
- Cumulative glycemic exposure and microvascular complications in insulin-dependent diabetes mellitus. The glycemic threshold revisitedArchives of Internal Medicine, 1997
- Procedures for setting normal valuesNeurology, 1995
- CLINICAL AND NEUROPATHOLOGICAL CRITERIA FOR THE DIAGNOSIS AND STAGING OF DIABETIC POLYNEUROPATHYBrain, 1985
- Acute hyperosmolar hyperglycemia causes axonal shrinkage and reduced nerve conduction velocityExperimental Neurology, 1981